System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Erwan Donal is an expert in Cardiology at Centre Hospitalier Universitaire de Rennes (France). As of October 2026, ScienceLeadR ranks Erwan Donal in the top 1% of experts worldwide for Tricuspid Valve Insufficiency, Mitral Valve Insufficiency and Cardiomyopathies. Erwan Donal has authored 1,110 publications, the most recent in 2026, and is an investigator in 65 clinical trials, 20 of them ongoing. SLR score: 4,802 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Erwan Donal Centre Hospitalier Universitaire de Rennes France
4 802 ScienceLeadR Reputation 4802

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Medical Imaging - Public Health - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Rennes

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1110

Citations

Citations: 47 856 1st author: 172 Last author: 209 Unique author: 9

Main journals

Eur Heart J Cardiovasc Imaging 162
Eur Heart J 88
EUR HEART J-CARD IMG 61
Arch Cardiovasc Dis 52
Archives of Cardiovascular Diseases Supplements 48

Best Journals

Eur Heart J 41
N Engl J Med 8
Circulation 6

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Liver Extracellular Volume in Patients With Tricuspid Regurgitation: A Novel Prognostic Marker.
PMID 42944652 — heart failure, liver, tricuspid valve insufficiency		JACC Cardiovasc Imaging20260
AI-assisted handheld echocardiography for hospital bedside cardiac triage: The prospective OPTIMUST implementation study.
PMID 42749085 — safety, triage, workflow, cardiology, physicians, echocardiography, artificial intelligence		Int J Cardiol20261
Genetic susceptibility in Takotsubo syndrome: a candidate gene association analysis in the French TAKOGENE cohort.
PMID 42863705 — genes, stress, physiological, genetic predisposition to disease, population control, sex, polymorphism, single nucleotide, genetic diseases, inborn, cardiomyopathies, takotsubo cardiomyopathy		Eur J Med Genet20260
Rivaroxaban for Stroke Prevention in Hypertrophic Cardiomyopathy Without Atrial Fibrillation and With Impaired Left Atrial Reservoir Strain: Design and Rationale of the LA-HCM Randomized Trial.
PMID 42844166 — stroke, rivaroxaban, atrial fibrillation, cardiomyopathy, hypertrophic, cardiomyopathies		Eur Heart J Cardiovasc Imaging20260
Impact of Tricuspid Regurgitation on Outcomes After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation: The PRIME-MR Registry.
PMID 42723620 — registries, mortality, cardiovascular surgical procedures, heart failure, tricuspid valve insufficiency, mitral valve insufficiency		Circ Cardiovasc Interv20260

Clinical Studies 65

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 14 Study Director: 1

By phase:

N/A 40
Phase 3 17
Phase 2 3
Phase 1 2
Phase 3/Phase 4 2
Phase 2/Phase 3 1

By status:

Completed 28
Recruiting 13
Unknown 9
Active not recruiting 7
Terminated 5
Enrolling by invitation 2
Not yet recruiting 1

By type:

Interventional 42
Observational 23

By Monocentric/Multicentric:

monocentric 16
multicentric2to4 5
multicentric5to9 7
multicentricup10 37

Main Topics

Cohort/Consortium Investigators 14

Ongoing Clinical Trials

20 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
CLEOPATTRA A research study to look at the effects of treatment with a medicine called coramitug (NNC6019 0001) in people with heart failure due to ATTR amyloidosis
2024-518899-31-00 — heart failure, heart, prealbumin, amyloidosis, research, therapeutics, amyloid, cardiomyopathies, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis		Phase 3Recruiting2025
A Study to Evaluate Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
2024-518343-38-00 — safety, prealbumin, amyloidosis, therapeutics, cardiomyopathies, transthyretin amyloidosis		Phase 3Active not recruiting2025
ATHENA A research study looking into how ziltivekimab works compared to placebo in people with heart failure and inflammation
2023-506988-34-00 — heart failure, heart, signs and symptoms, research		Phase 3Active not recruiting2024
A study to determine if ALXN2220 is effective safe and tolerable in adults with Transthyretin Amyloid Cardiomyopathy (ATTR CM)
2023-506669-70-00 — safety, prealbumin, amyloid, cardiomyopathies, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis		Phase 3Active not recruiting2024
TRITON CM A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
2024-519917-72-00 — safety, prealbumin, amyloidosis, therapeutics, cardiomyopathies, transthyretin amyloidosis		Phase 3Not yet recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS